HIV-1_NN
Vpr_NN
suppresses_VBZ
immune_JJ
activation_NN
and_CC
apoptosis_NN
through_IN
regulation_NN
of_IN
nuclear_JJ
factor_NN
kappa_NN
B_NN
-LCB-_-LRB-
see_VB
comments_NNS
-RCB-_-RRB-

The_DT
HIV-1_NN
accessory_JJ
gene_NN
product_NN
Vpr_NN
can_MD
influence_VB
viral_JJ
pathogenesis_NN
by_IN
affecting_VBG
viral_JJ
replication_NN
as_RB
well_RB
as_IN
host_NN
cell_NN
transcription_NN
and_CC
proliferation_NN
._.

We_PRP
have_VBP
investigated_VBN
the_DT
effects_NNS
of_IN
Vpr_NN
on_IN
host_NN
cell_NN
activation_NN
and_CC
confirm_VBP
that_IN
it_PRP
influences_VBZ
cellular_JJ
proliferation_NN
._.

However_RB
,_,
we_PRP
have_VBP
also_RB
found_VBN
that_IN
Vpr_NN
modulates_VBZ
T-cell_NN
receptor_NN
-LRB-_-LRB-
TCR_NN
-RRB-_-RRB-
-_:
triggered_JJ
apoptosis_NN
in_IN
a_DT
manner_NN
similar_JJ
to_TO
that_DT
of_IN
glucocorticoids_NNS
._.

In_IN
the_DT
absence_NN
of_IN
TCR-mediated_JJ
activation_NN
,_,
Vpr_NN
induces_VBZ
apoptosis_NN
whereas_IN
in_IN
its_PRP$
presence_NN
,_,
Vpr_NN
interrupts_VBZ
the_DT
expected_VBN
induction_NN
of_IN
apoptosis_NN
._.

This_DT
regulation_NN
of_IN
apoptosis_NN
is_VBZ
linked_VBN
to_TO
Vpr_NN
suppression_NN
of_IN
NF-kappa_NN
B_NN
activity_NN
via_IN
the_DT
induction_NN
of_IN
I_NN
kappa_NN
B_NN
,_,
an_DT
inhibitor_NN
of_IN
NF-kappa_NN
B_NN
._.

Further_RB
,_,
Vpr_NN
suppresses_VBZ
expression_NN
of_IN
IL-2_NN
,_,
IL-10_NN
,_,
IL-12_NN
,_,
TNF_NN
alpha_NN
and_CC
IL-4_NN
,_,
all_DT
of_IN
which_WDT
are_VBP
NF-kappa_NN
B-dependent_JJ
._.

The_DT
effects_NNS
of_IN
Vpr_NN
could_MD
be_VB
reversed_VBN
by_IN
RU486_NN
._.

Our_PRP$
finding_NN
that_IN
Vpr_NN
can_MD
regulate_VB
NF-kappa_NN
B_NN
supports_VBZ
the_DT
hypothesis_NN
that_IN
some_DT
aspects_NNS
of_IN
viral_JJ
pathogenesis_NN
are_VBP
the_DT
consequence_NN
of_IN
cell_NN
dysregulation_NN
by_IN
Vpr_NN
._.

